4-(1-ethylpyrrolidin-3-yl)-1,4-benzoxazin-3-one

ADVERTISEMENT

Identification

Molecular formula
C14H18N2O2
CAS Number
1036393-05-1
IUPAC Name
4-(1-ethylpyrrolidin-3-yl)-1,4-benzoxazin-3-one
Molecular Weight
230.29g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.2700g/cm3
Appearance
may vary slightly based on the purity and specific form it is in, such as being a crystalline solid or amorphous powder.
Interesting facts

Interesting Facts about 4-(1-Ethylpyrrolidin-3-yl)-1,4-benzoxazin-3-one

The compound 4-(1-ethylpyrrolidin-3-yl)-1,4-benzoxazin-3-one is a fascinating member of the benzoxazinoid family, which has garnered interest for its potential biological activities. Here are some intriguing aspects of this compound:

  • Diverse Applications: This compound is not only a subject of academic curiosity but also a candidate for various applications in medicinal chemistry due to its structural features, which can influence biological interactions.
  • Bioactivity Potential: Compounds like these often exhibit antioxidant and anti-inflammatory properties, making them valuable in the development of therapeutic agents.
  • Natural Sources: Benzoxazinoids are commonly found in plants, particularly in the Poaceae family (grasses), which have significant implications for ecological interactions and plant defense mechanisms.
  • Structural Complexity: The presence of the pyrrolidine ring adds an interesting layer of complexity to its reactivity and interaction with biological targets, contributing to its pharmacological profile.

Researchers are particularly interested in the compounds within this class for their potential roles in promoting health and combating disease. As they examine the various mechanisms of action and assess the compound's efficacy through *in vitro* and *in vivo* studies, the insights gained could lead to groundbreaking discoveries in medicinal chemistry.

In summary, 4-(1-ethylpyrrolidin-3-yl)-1,4-benzoxazin-3-one embodies the exciting intersection of chemistry and biology, highlighting the importance of structural diversity in the pursuit of novel therapeutic compounds.

ADVERTISEMENT